134 related articles for article (PubMed ID: 3127394)
1. Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells.
Ye RD; Wun TC; Sadler JE
J Biol Chem; 1988 Apr; 263(10):4869-75. PubMed ID: 3127394
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract][Full Text] [Related]
3. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin.
Ye RD; Ahern SM; Le Beau MM; Lebo RV; Sadler JE
J Biol Chem; 1989 Apr; 264(10):5495-502. PubMed ID: 2494165
[TBL] [Abstract][Full Text] [Related]
4. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
Ye RD; Wun TC; Sadler JE
J Biol Chem; 1987 Mar; 262(8):3718-25. PubMed ID: 3029122
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
6. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
7. The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity.
von Heijne G; Liljeström P; Mikus P; Andersson H; Ny T
J Biol Chem; 1991 Aug; 266(23):15240-3. PubMed ID: 1714455
[TBL] [Abstract][Full Text] [Related]
8. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.
Ginsburg D; Zeheb R; Yang AY; Rafferty UM; Andreasen PA; Nielsen L; Dano K; Lebo RV; Gelehrter TD
J Clin Invest; 1986 Dec; 78(6):1673-80. PubMed ID: 3097076
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
Wohlwend A; Belin D; Vassalli JD
J Exp Med; 1987 Feb; 165(2):320-39. PubMed ID: 2434595
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of plasminogen activator inhibitor by oxidants.
Lawrence DA; Loskutoff DJ
Biochemistry; 1986 Oct; 25(21):6351-5. PubMed ID: 3098287
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
Mikus P; Urano T; Liljeström P; Ny T
Eur J Biochem; 1993 Dec; 218(3):1071-82. PubMed ID: 7506655
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion.
Wohlwend A; Belin D; Vassalli JD
J Immunol; 1987 Aug; 139(4):1278-84. PubMed ID: 3112228
[TBL] [Abstract][Full Text] [Related]
13. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
Rehemtulla A; Gates J; Hart DA
Comp Biochem Physiol B; 1987; 88(1):277-83. PubMed ID: 3119281
[TBL] [Abstract][Full Text] [Related]
14. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.
Pannekoek H; Veerman H; Lambers H; Diergaarde P; Verweij CL; van Zonneveld AJ; van Mourik JA
EMBO J; 1986 Oct; 5(10):2539-44. PubMed ID: 2430793
[TBL] [Abstract][Full Text] [Related]
15. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1.
Zeheb R; Gelehrter TD
Gene; 1988 Dec; 73(2):459-68. PubMed ID: 3149611
[TBL] [Abstract][Full Text] [Related]
16. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
17. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
18. Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment.
Knudsen BS; Nachman RL
J Biol Chem; 1988 Jul; 263(19):9476-81. PubMed ID: 2967824
[TBL] [Abstract][Full Text] [Related]
19. Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
Ny T; Sawdey M; Lawrence D; Millan JL; Loskutoff DJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6776-80. PubMed ID: 3092219
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.
Lucore CL; Fujii S; Wun TC; Sobel BE; Billadello JJ
J Biol Chem; 1988 Nov; 263(31):15845-8. PubMed ID: 2846525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
